Skin Cancers: Update on Personalized Treatment and Management
A special issue of Journal of Personalized Medicine (ISSN 2075-4426). This special issue belongs to the section "Personalized Therapy and Drug Delivery".
Deadline for manuscript submissions: 20 February 2025 | Viewed by 805
Special Issue Editor
2. Dermatology Unit, Fondazione IRCCS Ca’ Granda, Ospedale Maggiore Policlinico, 20122 Milan, Italy
Interests: dermoscopy; dermatopathology; tropical dermatology; ultrasonography; history of medicine
Special Issue Information
Dear Colleagues,
Skin cancers, including basal cell carcinoma, squamous cell carcinoma, and melanoma, have continued to rise globally over the past few decades, and statistics have shown that skin cancer is one of the three most common forms of cancer. Fortunately, novel, more effective treatments for various types of skin cancer are in development, and early diagnosis and the exploration of innovative treatments are particularly important.
This Special Issue will focus on recent advances in skin cancer prevention, diagnosis, and treatment and the latest insights gained by clinical researchers, with a focus on how to personalize these new advances in clinical practice.
Dr. Nazzaro Gianluca
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Journal of Personalized Medicine is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- basal cell carcinoma
- squamous cell carcinoma
- melanoma
- skin cancers
- dermoscopy
- ultrasonography
- immunotherapy
- biomarker
- prevention
- diagnosis
- treatment
- innovative treatments
- prognosis
- personalized
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.
